Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study
B Bortnick, N El-Khalili, M Banov, D Adson… - Journal of affective …, 2011 - Elsevier
BACKGROUND: Evaluate the efficacy and tolerability of extended release quetiapine
fumarate (quetiapine XR) once-daily monotherapy for patients with major depressive …
fumarate (quetiapine XR) once-daily monotherapy for patients with major depressive …
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study
B Bortnick, N El-Khalili, M Banov… - Journal of affective …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Evaluate the efficacy and tolerability of extended release quetiapine fumarate
(quetiapine XR) once-daily monotherapy for patients with major depressive disorder (MDD) …
(quetiapine XR) once-daily monotherapy for patients with major depressive disorder (MDD) …
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study
B Bortnick, N El-Khalili, M Banov, D Adson… - Journal of Affective …, 2011 - infona.pl
Evaluate the efficacy and tolerability of extended release quetiapine fumarate (quetiapine
XR) once-daily monotherapy for patients with major depressive disorder (MDD). In this 10 …
XR) once-daily monotherapy for patients with major depressive disorder (MDD). In this 10 …
[PDF][PDF] Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized …
B Bortnick, N El-Khalili, M Banov, D Adson… - Journal of Affective …, 2011 - academia.edu
Background: Evaluate the efficacy and tolerability of extended release quetiapine fumarate
(quetiapine XR) once-daily monotherapy for patients with major depressive disorder (MDD) …
(quetiapine XR) once-daily monotherapy for patients with major depressive disorder (MDD) …
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study.
B Bortnick, N El-Khalili, M Banov, D Adson… - Journal of Affective …, 2011 - psycnet.apa.org
Background: Evaluate the efficacy and tolerability of extended release quetiapine fumarate
(quetiapine XR) once-daily monotherapy for patients with major depressive disorder (MDD) …
(quetiapine XR) once-daily monotherapy for patients with major depressive disorder (MDD) …
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.
B Bortnick, N El-Khalili, M Banov, D Adson… - Journal of Affective …, 2010 - europepmc.org
Background Evaluate the efficacy and tolerability of extended release quetiapine fumarate
(quetiapine XR) once-daily monotherapy for patients with major depressive disorder (MDD) …
(quetiapine XR) once-daily monotherapy for patients with major depressive disorder (MDD) …
[引用][C] Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized …
B BORTNICK, N EL-KHALILI, M BANOV… - Journal of affective …, 2011 - pascal-francis.inist.fr
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy
in major depressive disorder: A placebo-controlled, randomized study CNRS Inist …
in major depressive disorder: A placebo-controlled, randomized study CNRS Inist …
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study
B Bortnick, N El-Khalili, M Banov, D Adson… - Journal of Affective …, 2011 - infona.pl
Evaluate the efficacy and tolerability of extended release quetiapine fumarate (quetiapine
XR) once-daily monotherapy for patients with major depressive disorder (MDD). In this 10 …
XR) once-daily monotherapy for patients with major depressive disorder (MDD). In this 10 …